These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38266401)

  • 1. Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification.
    Villiger AS; Zurbriggen S; Imboden S; Solass W; Christe L; Saner FAM; Gmür A; Rau TT; Mueller MD; Siegenthaler F
    Gynecol Oncol; 2024 Mar; 182():148-155. PubMed ID: 38266401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of lymphovascular space invasion according to the molecular subgroups in endometrial cancer.
    Siegenthaler F; Epstein E; Büchi CA; Gmür A; Saner FACM; Rau TT; Carlson JW; Mueller MD; Imboden S
    Int J Gynecol Cancer; 2023 Nov; 33(11):1702-1707. PubMed ID: 37666529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
    Bosse T; Nout RA; McAlpine JN; McConechy MK; Britton H; Hussein YR; Gonzalez C; Ganesan R; Steele JC; Harrison BT; Oliva E; Vidal A; Matias-Guiu X; Abu-Rustum NR; Levine DA; Gilks CB; Soslow RA
    Am J Surg Pathol; 2018 May; 42(5):561-568. PubMed ID: 29505428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of positive peritoneal cytology for recurrence and survival in patients with endometrial cancer.
    Ueno Y; Toyoshima M; Shigemi D; Yumori A; Wakabayashi R; Kitagawa M; Konnai K; Onose R; Suzuki S; Kato H
    J Obstet Gynaecol Res; 2023 Jan; 49(1):304-313. PubMed ID: 36210139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database.
    Seagle BL; Alexander AL; Lantsman T; Shahabi S
    Am J Obstet Gynecol; 2018 Mar; 218(3):329.e1-329.e15. PubMed ID: 29223598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to first recurrence, pattern of recurrence, and survival after recurrence in endometrial cancer according to the molecular classification.
    Siegenthaler F; Lindemann K; Epstein E; Rau TT; Nastic D; Ghaderi M; Rydberg F; Mueller MD; Carlson J; Imboden S
    Gynecol Oncol; 2022 May; 165(2):230-238. PubMed ID: 35277281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Lymphovascular Space Invasion and Cytology in the Prognosis of Endometrial Cancer.
    Ozdemir CY; Arioz DT; Celik F; Cicekli N; Chkhikvadze M; Bilir F; Yılmaz S; Vatansever N
    Discov Med; 2024 Feb; 36(181):366-371. PubMed ID: 38409841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of positive peritoneal cytology in endometrial cancer patients.
    Behtash N; Sheikhhasani S; Nezamabadi V
    J Obstet Gynaecol; 2022 Aug; 42(6):2336-2340. PubMed ID: 35470766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis.
    Tebeu PM; Popowski Y; Verkooijen HM; Bouchardy C; Ludicke F; Usel M; Major AL
    Br J Cancer; 2004 Aug; 91(4):720-4. PubMed ID: 15266316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCGA molecular subgroups of endometrial carcinoma in ovarian endometrioid carcinoma: A quantitative systematic review.
    D'Alessandris N; Travaglino A; Santoro A; Arciuolo D; Scaglione G; Raffone A; Inzani F; Zannoni GF
    Gynecol Oncol; 2021 Nov; 163(2):427-432. PubMed ID: 34446267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
    Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
    Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator : Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer.
    Siegenthaler F; Johann S; Imboden S; Samartzis N; Ledermann-Liu H; Sarlos D; Eberhard M; Mueller MD
    Ann Surg Oncol; 2022 Dec; 29(13):8320-8333. PubMed ID: 36057902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.
    Lee B; Suh DH; Kim K; No JH; Kim YB
    Jpn J Clin Oncol; 2016 Aug; 46(8):711-7. PubMed ID: 27207885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus.
    Kasamatsu T; Onda T; Katsumata N; Sawada M; Yamada T; Tsunematsu R; Ohmi K; Sasajima Y; Matsuno Y
    Br J Cancer; 2003 Jan; 88(2):245-50. PubMed ID: 12610496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
    Wang L; Li L; Wu M; Lang J
    Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
    León-Castillo A; de Boer SM; Powell ME; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Singh N; Pollock PM; Bessette P; Fyles A; Haie-Meder C; Smit VTHBM; Edmondson RJ; Putter H; Kitchener HC; Crosbie EJ; de Bruyn M; Nout RA; Horeweg N; Creutzberg CL; Bosse T;
    J Clin Oncol; 2020 Oct; 38(29):3388-3397. PubMed ID: 32749941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.